drugset / Trial / NCT02556736
AGN-151597 (Formerly RST-001) Phase I/II Trial for Advanced Retinitis Pigmentosa
Non-randomizedSequentialOpen-labelTreatment
Summary
All participants in phase 1 and phase 2a had hand motion visual acuity or worse. If efficacy was demonstrated from phase 1, better vision subjects could be enrolled; however, efficacy was not demonstrated.
Timeline
- Start
- 2015-12-14
- Primary completion
- 2020-06-01
- Completion
- 2024-10-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RST-001 | Gene therapy (AAV / viral vector) | — | Intravitreal |